Editor-in-Chief Emeritus Pick of Papers
Free access for our readers
For each issue of Radiotherapy and Oncology, the Editor-in-Chief Emeritus Jens Overgaard, picks his favourite papers.
- Compared to paediatric patients, indications for proton therapy (PT) for adult patients are less acknowledged . Although radiation of intra-ocular tumours and chordoma/chondrosarcoma of the skull base are currently regarded as standard indications for adult patients in virtually all countries, there are major differences regarding patient selection for PT across European countries and even between centres in the same country [2–4]. This is especially true for adult patients who would normally be treated with photon therapy but may benefit from PT because of more favourable dose distributions.
- Several national guidelines consider proton therapy an optimal radiation modality for treating pediatric tumors and reducing treatment toxicities [1–6]. Compared with photons, protons have better physical properties providing clear dosimetric advantages to improve treatment conformality and lower doses to surrounding normal tissues [7–9]. This could have considerable clinical benefits to reduce treatment toxicities while maintaining or improving cure rates, especially when treating young patients with a tumor located close to critical normal tissues, such as the brain stem, eyes and spinal cord.
- Radiotherapy plays an important role in the management of childhood cancer, with the primary aim of achieving the highest likelihood of cure with the lowest risk of radiation-induced morbidity. Proton therapy (PT) provides an undisputable advantage by reducing the radiation ‘bath’ dose delivered to non-target structures/volume while optimally covering the tumor with tumoricidal dose. This treatment modality comes, however, with an additional costs compared to conventional radiotherapy that could put substantial financial pressure to the health care systems with societal implications.
- For unbiased comparison of different radiation modalities and techniques, consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose constraints is warranted. Following the publication of a digital, online atlas for OAR delineation in neuro-oncology by the same group, we assessed the brain OAR-dose constraints in a follow-up study.
- To create a digital, online atlas for organs at risk (OAR) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging.